Lawsuit Alleges NuvaRing Manufacturer Downplayed Risks, Endangered Consumers
By Robert J. Boumis
Krysta Schraff has filed a lawsuit against Organon USA alleging that its contraceptive device NuvaRing caused her serious health complications. She is seeking compensation for her alleged injuries, including a blood clot in her lung (pulmonary embolism).
NuvaRing is a type of contraceptive device designed like a flexible ring. The ring is designed to slowly release a synthetic hormone, progestin, which prevents ovulation, blocking pregnancy. However, birth control using this hormone, and the NuvaRing device in particular are allegedly associated with an increased risk of developing blood clot-related medical problems, like stroke and pulmonary embolism.
According to the lawsuit, Schraff used NuvaRing from May of 2012 up through December of the same year. In Late December 2012, Schraff was diagnosed with a pulmonary embolism, a blood clot lodged in the critical, main blood vessels to the lungs.
The NuvaRing lawsuit asserts that the manufacturers knew – or reasonably should have known – of the risk of serious health problems potentially linked to NuvaRing. Specifically, the lawsuit holds that it was known, prior to Schraff’s use of the device, that the active ingredient could cause blood clot-related complications, including deep vein thrombosis (DVT), PE, and stroke. All of these conditions are life-threatening medical emergencies, and require emergency medical care, and may cause permanent complications, requiring continuing medical care and monitoring.
The NuvaRing lawsuit further asserts that the manufacturers deliberately downplayed the risks, preventing health care professionals and patients like Schraff from having all of the information they needed to make informed decisions regarding their medical care. The lawsuit states that the prescribing information that accompanies the NuvaRing contraceptive device failed to warn patients of the risk of DVT, PE, stroke and death associated with the synthetic hormones used by the device. According to the lawsuit, the accompanying information asserts that the risks associated with NuvaRing are comparable to oral birth control pills, though the lawsuit holds that this is not the case.
The case is Krysta Schraff, vs. Oragnon USA Incorporated, a New Jersey Corporation for Profit, et al, Case No. 0:13-cv-62382, filed in the United States District Court for the Southern District of Florida, Fort Lauderdale Division.
If you took NuvaRing after Jan. 1, 2011, and suffered deep vein thrombosis or pulmonary embolism, you may qualify for compensation. You can start to explore your options by visiting the NuvaRing Birth Control Class Action Lawsuit Settlement & Investigation. Here, you can enter information about your situation for a legal review by a trained expert with a background in this type of litigation. The initial consultation is completely free of charge and from here, you can receive additional guidance on the best steps to take in your exact situation.
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
Suing for unpaid wages in California: Recover unpaid overtime, back pay and more
April 2, 2026 | Legal News
